Header

UZH-Logo

Maintenance Infos

Bortezomib-induced skin eruption


Sanchez-Politta, S; Favet, L; Kerl, K; Dietrich, P Y; Piguet, V (2008). Bortezomib-induced skin eruption. Dermatology, 216(2):156-158.

Abstract

Bortezomib (Velcad) is a proteasome inhibitor recently developed and mainly used for the treatment of multiple myeloma. Bortezomib represents a novel class of drugs functioning as proteasome inhibitors. Skin complications of bortezomib treatment are very frequent but poorly characterized. We describe the case of a patient who developed erythematous and edematous plaques after treatment with bortezomib. This case illustrates one of the potential reactions associated with bortezomib administration and underlines the need to recognize and report cutaneous side effects of this new drug.

Abstract

Bortezomib (Velcad) is a proteasome inhibitor recently developed and mainly used for the treatment of multiple myeloma. Bortezomib represents a novel class of drugs functioning as proteasome inhibitors. Skin complications of bortezomib treatment are very frequent but poorly characterized. We describe the case of a patient who developed erythematous and edematous plaques after treatment with bortezomib. This case illustrates one of the potential reactions associated with bortezomib administration and underlines the need to recognize and report cutaneous side effects of this new drug.

Statistics

Citations

Dimensions.ai Metrics
12 citations in Web of Science®
14 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

307 downloads since deposited on 18 Feb 2009
66 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Dermatology
Language:English
Date:2008
Deposited On:18 Feb 2009 12:27
Last Modified:26 Jun 2022 10:09
Publisher:Karger
ISSN:1018-8665
OA Status:Green
Publisher DOI:https://doi.org/10.1159/000111513
PubMed ID:18216478
  • Content: Published Version